"La Fondazione Santa Lucia IRCCS è un Istituto di Ricovero e Cura a Carattere Scientifico specializzato in neuroscienze e neuroriabilitazione. Accanto all’attività di ricerca, è sede di Corsi di Laurea e di Specializzazione in collaborazione con le Università di Roma Tor Vergata e Sapienza. Il suo Ospedale è dotato di 325 posti letto di neuroriabilitazione di alta specialità che, in convenzione con il SSN, garantiscono cure a pazienti colpiti da gravi esiti di ictus cerebrale, coma, traumi cranici e lesioni del midollo spinale. Presso la Fondazione sono in cura più di 200 bambini affetti da gravi cerebrolesioni e malattie rare. La produzione scientifica del settore Ricerca registra una media di 2.000 punti di impact factor."

During the past decade, Santa Lucia Foundation conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Santa Lucia Foundation" #1 sponsor was "I.R.C.C.S. Fondazione Santa Lucia" with 15 trials, followed by "Biogen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Istituti Clinici Scientifici Maugeri SpA" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Lucia Foundation" #1 collaborator was "I.R.C.C.S. Fondazione Santa Lucia" with 3 trials as a collaborator, "Università degli studi di Roma Foro Italico" with 2 trials as a collaborator, "APSS Trento" with 1 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "Azienda Ospedaliera San Gerardo di Monza" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Santa Lucia Foundation" are "Stroke" (8 trials), "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (4 trials), "Parkinson Disease" (3 trials) and "Dementia" (2 trials). Many other conditions were trialed in "Santa Lucia Foundation" in a lesser frequency.

Most popular intervention types in "Santa Lucia Foundation" are "Drug" (13 trials), "Other" (11 trials), "Device" (9 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION" (3 trials), "Aticaprant" (2 trials), "Aducanumab" (1 trials) and "Aducanumab (BIIB037)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Lucia Foundation" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Santa Lucia Foundation". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Santa Lucia Foundation, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Santa Lucia Foundation, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".

Santa Lucia Foundation has several departments that took part in Clinical trials: "Fondazione Santa Lucia IRCCS; Neurologia e Riabilitazione Neurologica" - 4 trials, "Neurorehabilitation Units- Fondazione Santa Lucia, IRCCS" - 3 trials